OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Methylene Blue Is a Nonspecific Protein–Protein Interaction Inhibitor with Potential for Repurposing as an Antiviral for COVID-19
Sung-Ting Chuang, Henrietta Papp, Anett Kuczmog, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 621-621
Open Access | Times Cited: 14

Showing 14 citing articles:

Study of the Lipophilicity and ADMET Parameters of New Anticancer Diquinothiazines with Pharmacophore Substituents
Daria Klimoszek, Małgorzata Jeleń, Małgorzata Dołowy, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 725-725
Open Access | Times Cited: 11

Targeting of Tetraspanin CD81 with Monoclonal Antibodies and Small Molecules to Combat Cancers and Viral Diseases
Christian Bailly, Xavier Thuru
Cancers (2023) Vol. 15, Iss. 7, pp. 2186-2186
Open Access | Times Cited: 22

A Novel Approach of Combining Methylene Blue Photodynamic Inactivation, Photobiomodulation and Oral Ingested Methylene Blue in COVID-19 Management: A Pilot Clinical Study with 12-Month Follow-Up
Juliette Hepburn, Susan Williams-Lockhart, René‐Jean Bensadoun, et al.
Antioxidants (2022) Vol. 11, Iss. 11, pp. 2211-2211
Open Access | Times Cited: 17

Exploring autophagy in treating SARS-CoV-2 spike protein-related pathology
Matthew Halma, Paul E. Marik, Yusuf M. Saleeby
Endocrine and Metabolic Science (2024) Vol. 14, pp. 100163-100163
Open Access | Times Cited: 3

Application of methylene blue for the prevention and treatment of COVID-19: A narrative review.
Elaheh Emadi, Daryoush Hamidi Alamdari, Davood Attaran, et al.
PubMed (2024) Vol. 27, Iss. 7, pp. 780-792
Closed Access | Times Cited: 3

Molecular mechanisms of human coronavirus NL63 infection and replication
Gino Castillo, Juan Carlos Mora-Díaz, Mary Breuer, et al.
Virus Research (2023) Vol. 327, pp. 199078-199078
Open Access | Times Cited: 5

SARS‐CoV‐2 in digital era: Diagnostic techniques and importance of nucleic acid quantification with digital PCRs
Neeraj Kumar, S. Aradhana, Harleen, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 5
Closed Access | Times Cited: 3

Romanowsky staining: history, recent advances and future prospects from a chemistry perspective
Valeriy Kalinin, Pavel Padnya, Ivan I. Stoikov
Biotechnic & Histochemistry (2023) Vol. 99, Iss. 1, pp. 1-20
Closed Access | Times Cited: 2

Methylene blue for COVID-19 ARDS: insights from a randomized Clinical Trial
Zahra Sadat Sanei, Fatemeh Shahrahmani, Behrooz Khaleghi Manesh, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access

Exploring Therapeutic Applications of Autophagy in Spike Protein-Related Pathology
Matthew Halma, Paul E. Marik, Yusuf Saleeby
(2023)
Open Access | Times Cited: 1

Protein-protein interaction-based high throughput screening for adenylyl cyclase 1 inhibitors: Design, implementation, and discovery of a novel chemotype
Tiffany Dwyer, Joseph B. O’Brien, Christopher P. Ptak, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 2

From Palliation to Cure: Two Case Reports on Methylene Blue Benefits in Elderly, Frail, and Critically Ill COVID-19 Patients
Marco Ceresa, Giuliana Cassinelli, Andrea De Gasperi
Annals of Case Reports (2022) Vol. 7, Iss. 6
Open Access

Page 1

Scroll to top